Sistemde güncelleme ve geliştirme çalışmaları devam etmektedir

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study

KIRIKKALE UNIVERSITY Career
Staff Login Login

Publication

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study

01 Ocak 2024 Makale Özgün Makale Google Scholar
Authors
PROFESÖR SELİM YALÇIN

Atıf kopyala

P. S. YALÇIN (2024). The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study. *International Journal of Clinical Oncology*, 29(3), 258–264. https://doi.org/10.1007/s10147-023-02460-5

Yayın bilgileri

Dergi International Journal of Clinical Oncology
DOI 10.1007/s10147-023-02460-5
Veri tabanı SCI-Expanded; Google Scholar
Cilt / Sayı 29 / 3
Sayfa 258 – 264
Yayına Git

Atıf verisi 15 Kasım 2026 tarihinde güncellendi.

Dergi: International Journal of Clinical Oncology | Yıl: 2024 | Cilt/Sayı: 29/3 | Sayfa: 258-264 | DOI: 10.1007/s10147-023-02460-5 | Yazarlar: YILDIRIM HASAN ÇAĞRI,KUTLU YASİN,MUTLU EMEL,AYKAN MUSA BARIŞ,YALÇIN SELİM,KORKMAZ MUSTAFA,ŞAKALAR TEOMAN,CELAYİR ÖZDE MELİSA,KAYIKÇIOĞLU ERKAN,ASLAN FERİT,HAFIZOĞLU EMRE,ALTINTAŞ YUNUS EMRE,KESKİNKILIÇ MERVE,Chalabiyev Elvin,çelebi abdussamed,DURSUN BENGÜ,ÖZEN MİRAÇ

Citations by source

Kaynak Atıf
Google Scholar 11
Etkin 0

Yayın metrikleri (GS / WoS / Scopus)

11 Google Scholar Atıf
AI Assistant
Online